United Kingdom

People: Invacare Corp (IVC.N)

IVC.N on New York Stock Exchange

5:18pm GMT
Change (% chg)

$-0.09 (-1.80%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Gibeley, Marc 

Mr. Marc M. Gibeley is an Independent Director of Invacare Corp. Mr. Gibeley serves as Chief Executive Officer and Director of Scientific Intake Ltd. Co., a medical device and digital healthcare company focused on weight management and the prevention of obesity related chronic diseases, since October 2016. Prior to joining Scientific Intake, Mr. Gibeley served as Head of Diabetes Care North America for Roche Holding AG (SIX: RO), a leading research-focused pharmaceuticals and diagnostics healthcare company from 2011 through 2016. Mr. Gibeley served as the President and Chief Executive Officer of WaveRx, a venture-backed diabetes neuropathy medical device company, from 2008 through 2011. Prior to joining WaveRx, Mr. Gibeley worked for several consumer packaged goods companies, including Procter & Gamble (NYSE: PG), Eastman Kodak (NYSE: KODK) and Kraft Foods (NASDAQ: KHC). The Board concluded that Mr. Gibeley should serve as a Director of the Company primarily due to his extensive experience in leading and managing medical device companies that have undergone substantial changes and transformed to focus on marketing products directly to consumers. He has a wide range of management expertise, including in sales, marketing, finance, customer support and product launches, as well as in regulatory affairs, manufacturing, and operations and commercial development, which has been developed over a career in consumer products businesses at various stages of development. The Board believes that Mr. Gibeley’s background and experience will be valuable in contributing to the Board’s oversight of the Company’s strategy, finance and operations, particularly as the Company seeks to continue the transformation of its business and responds to the drive toward consumerism in the health care industry.

Basic Compensation

Total Annual Compensation, USD 60,000
Restricted Stock Award, USD 104,133
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 164,133

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Matthew Monaghan


Kathleen Leneghan


Anthony LaPlaca


Ralf Ledda


C. Martin Harris


Susan Alexander

As Of  31 Dec 2017